153 related articles for article (PubMed ID: 21849807)
1. Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative eales' disease.
Saxena S; Khanna VK; Pant AB; Meyer CH; Singh VK
Pathobiology; 2011; 78(5):261-5. PubMed ID: 21849807
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease.
Saxena S; Pant AB; Khanna VK; Agarwal AK; Singh K; Kumar D; Singh VK
Ocul Immunol Inflamm; 2009; 17(3):201-6. PubMed ID: 19585364
[TBL] [Abstract][Full Text] [Related]
3. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.
Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhury S; Mandal LK; Bhattacharya B
Retina; 2011; 31(7):1412-20. PubMed ID: 21394064
[TBL] [Abstract][Full Text] [Related]
4. Eales' disease: diagnosis and management.
Das T; Pathengay A; Hussain N; Biswas J
Eye (Lond); 2010 Mar; 24(3):472-82. PubMed ID: 20075970
[TBL] [Abstract][Full Text] [Related]
5. Raised platelet thiobarbituric acid-reacting substances in proliferative Eales' disease.
Srivastava P; Saxena S; Khanna VK; Kumar D; Nath R; Seth PK
Indian J Ophthalmol; 2000 Dec; 48(4):307-9. PubMed ID: 11340890
[TBL] [Abstract][Full Text] [Related]
6. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].
Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
Med Klin (Munich); 1995 Mar; 90(3):134-7. PubMed ID: 7723714
[TBL] [Abstract][Full Text] [Related]
7. Visualization of retinal vasculitis in Eales' disease.
Atmaca LS; Idil A; Gündüz K
Ocul Immunol Inflamm; 1993; 1(1-2):41-8. PubMed ID: 22827191
[TBL] [Abstract][Full Text] [Related]
8. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease.
Rajesh M; Sulochana KN; Coral K; Punitham R; Biswas J; Babu K; Ramakrishnan S
Indian J Ophthalmol; 2004 Jun; 52(2):139-44. PubMed ID: 15283219
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal steroids may facilitate treatment of Eales' disease (idiopathic retinal vasculitis): an interventional case series.
Ishaq M; Feroze AH; Shahid M; Baig MA; Ameen SS; Feroze SH; Chishti RA
Eye (Lond); 2007 Nov; 21(11):1403-5. PubMed ID: 16980931
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Eales' disease with scatter laser photocoagulation.
Magargal LE; Walsh AW; Magargal HO; Robb-Doyle E
Ann Ophthalmol; 1989 Aug; 21(8):300-2. PubMed ID: 2478067
[TBL] [Abstract][Full Text] [Related]
11. Decreased platelet membrane fluidity in retinal periphlebitis in Eales' disease.
Saxena S; Srivastava P; Kumar D; Khanna VK; Seth PK
Ocul Immunol Inflamm; 2006 Apr; 14(2):113-6. PubMed ID: 16597541
[TBL] [Abstract][Full Text] [Related]
12. Massive vascular endothelium growth factor (VEGF) expression in Eales' disease.
Perentes Y; Chan CC; Bovey E; Uffer S; Herbort CP
Klin Monbl Augenheilkd; 2002 Apr; 219(4):311-4. PubMed ID: 12022026
[TBL] [Abstract][Full Text] [Related]
13. Increased homocysteine, homocysteine-thiolactone, protein homocysteinylation and oxidative stress in the circulation of patients with Eales' disease.
Bharathselvi M; Biswas J; Selvi R; Coral K; Narayanasamy A; Ramakrishnan S; Sulochana KN
Ann Clin Biochem; 2013 Jul; 50(Pt 4):330-8. PubMed ID: 23761385
[TBL] [Abstract][Full Text] [Related]
14. Association of Mycobacterium tuberculosis in the causation of Eales' disease: an institutional experience.
; Singh UB; Mohapatra S; Wagh VK; Porwal C; Kaushik A
Indian J Med Microbiol; 2015 Feb; 33 Suppl():43-5. PubMed ID: 25657155
[TBL] [Abstract][Full Text] [Related]
15. [Eales' disease].
Errera MH; Pratas A; Goldschmidt P; Sedira N; Sahel JA; Benesty J
J Fr Ophtalmol; 2016 May; 39(5):474-82. PubMed ID: 27185661
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
17. Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage.
Bhooma V; Sulochana KN; Biswas J; Ramakrishnan S
Curr Eye Res; 1997 Feb; 16(2):91-5. PubMed ID: 9068938
[TBL] [Abstract][Full Text] [Related]
18. Association of mycobacteria with Eales' disease.
Therese KL; Deepa P; Therese J; Bagyalakshmi R; Biswas J; Madhavan HN
Indian J Med Res; 2007 Jul; 126(1):56-62. PubMed ID: 17890825
[TBL] [Abstract][Full Text] [Related]
19. Total antioxidant capacity in Eales' disease, uveitis & cataract.
Selvi R; Angayarkanni N; Biswas J; Ramakrishnan S
Indian J Med Res; 2011 Jul; 134(1):83-90. PubMed ID: 21808139
[TBL] [Abstract][Full Text] [Related]
20. [Changes of serum soluble P-selectin and tumor necrotic factor-alpha in patients with CMV induced acute coronary syndrome].
Wang XM; Li Y; Huang C; Zhang RH; Guo HT; Chen H; Wang HC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):149-51. PubMed ID: 16027783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
